Factors Associated With Aborted Whipple Procedures for Periampullary Carcinoma: A Multicenter Case-Control Study by the SAR Pancreatic Ductal Adenocarcinoma Disease Focus Panel
<b>BACKGROUND.</b> A number of patients with periampullary carcinoma deemed resectable on preoperative CT have their curative-intent surgery aborted on the basis of intraoperative findings. <b>OBJECTIVE.</b> This study sought to identify imaging and clinical factors associated with aborted curative-intent Whipple procedures for periampullary adenocarcinoma. <b>METHODS.</b> Ten U.S., Canadian, and French institutions contributed data to this retrospective case-control study of 360 adults (220 men, 140 women; mean age, 68.6 ± 8.4 [SD] years) with periampullary adenocarcinoma who underwent curative-intent Whipple procedures between January 2016 and December 2022. A total of 180 patients for whom the procedure was aborted (case group) were matched by sex and 5-year age blocks with 180 patients for whom the procedure was completed (control group). Covariates included cancer type, tumor size and resectability on CT, CT reconstruction slice thickness including by phase, number of phases, multiplanar imaging, reconstruction at the workstation, possible metastases reported, structured versus unstructured report, reporting radiologist's experience, hepatic steatosis, preoperative liver MRI, endoscopic ultrasound, ERCP, multidisciplinary review, neoadjuvant therapy and response, and serum CA 19-9 and CEA levels. Logistic regression was performed with ORs and 95% CIs. <b>RESULTS.</b> Whipple procedures were most frequently aborted because of metastases (67.2% [121/180]), followed by locally unresectable disease (27.8% [50/180]). Serum CA 19-9 levels of 37 U/mL or more were associated with aborted Whipple procedures with an OR of 3.75 (95% CI, 1.22-12.77) that increased to 5.47 (95% CI, 1.80-18.62) when a cutoff of 200 U/mL was applied. CT slice thickness ranged from 0.5 mm to 5 mm. CT examinations that used only slice thicknesses of 2.5 mm or more were independently associated with aborted Whipple procedures (OR = 4.28 [95% CI, 1.37-15.00]), including when assessing only pancreatic ductal adenocarcinoma. No other variables showed statistically significant association. <b>CONCLUSION.</b> Elevated serum CA 19-9 levels and preoperative CT using only slice thicknesses of 2.5 mm or more were associated with aborted curative-intent Whipple procedures. Many other imaging and clinical factors did not show an association. <b>CLINICAL IMPACT.</b> If curative-intent surgery is planned in patients with periampullary carcinoma, preoperative CT should be performed using reconstructions smaller than 2.5 mm to reduce the likelihood of incorrect staging.
Authors
- Hamza Ahmed Ibad (ORCID: https://orcid.org/0000-0003-1557-9484)
- Jessyca Matos Silva (ORCID: https://orcid.org/0000-0001-6896-9473)
- Zhen J. Wang (ORCID: https://orcid.org/0000-0002-2065-5296)
- Zoe Hu (ORCID: https://orcid.org/0000-0001-7353-4490)
- Lawrence C. E. Mbuagbaw (ORCID: https://orcid.org/0000-0001-5855-5461)
- Chenchan Huang (ORCID: https://orcid.org/0000-0002-9530-1206)
- Rina Nguyen
- Madeline Komar (ORCID: https://orcid.org/0009-0001-1842-9898)
- Leyo Ruo (ORCID: https://orcid.org/0000-0002-1598-3228)
- Lyndon Luk (ORCID: https://orcid.org/0000-0002-4468-3128)
- Sumit Rana (ORCID: https://orcid.org/0009-0007-5802-520X)
- Benjamin Angliviel
- Avinash Kambadakone (ORCID: https://orcid.org/0000-0001-6714-9190)
- Elizabeth M. Hecht (ORCID: https://orcid.org/0000-0002-4746-8415)
- Erik V. Soloff (ORCID: https://orcid.org/0000-0002-4473-6736)
- Candice W. Bolan (ORCID: https://orcid.org/0000-0002-9847-3599)
- Christian B. van der Pol (ORCID: https://orcid.org/0000-0002-1718-2619)
- Richard Kinh Gian (ORCID: https://orcid.org/0000-0002-6554-0310)
- Jena Depetris (ORCID: https://orcid.org/0000-0002-2544-7496)
- Andrew D. Chung (ORCID: https://orcid.org/0000-0001-5114-4379)
- Linda Chi Hang Chu (ORCID: https://orcid.org/0000-0001-9729-2756)
- Atif Zaheer (ORCID: https://orcid.org/0000-0002-4824-6654)
- Samuel J. Galgano (ORCID: https://orcid.org/0000-0002-1592-9950)
- Hina Arif‐Tiwari (ORCID: https://orcid.org/0000-0003-0837-0682)
- Michael D. Kluger (ORCID: https://orcid.org/0000-0003-4311-078X)
- Jin Peng He (ORCID: https://orcid.org/0000-0001-9149-2247)
- Marc Zins (ORCID: https://orcid.org/0000-0001-5694-1238)
- Joy Liau (ORCID: https://orcid.org/0000-0002-3025-0268)
- Sulaiman Nanji
- Brock Hewitt
- Linda Van Le
- Mustafa Sabil
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Johns Hopkins University (US)
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- Queen's University (CA)
- Cornell University (US)
- Columbia University Irving Medical Center (US)
- Johns Hopkins Medicine (US)
- Jacksonville College (US)
- WinnMed (US)
- University of California System (US)
- University of Alabama at Birmingham (US)
- University of California San Diego (US)
- NYU Langone Health (US)
- Banner - University Medical Center Tucson (US)
- Mayo Clinic in Florida (US)
- Johns Hopkins Hospital (US)
- Weill Cornell Medicine (US)
- McMaster University (CA)
Publication Details
- Journal
- American Journal of Roentgenology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.2214/ajr.24.32160
- Citations
- 2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09